Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.

Autor: Scheurer, Michael E., Renke Zhou, Gilbert, Mark R., Bondy, Melissa L., Sulman, Erik P., Ying Yuan, Yanhong Liu, Vera, Elizabeth, Wendland, Merideth M., Youssef, Emad F., Stieber, Volker W., Komaki, Ritsuko R., Flickinger, John C., Kenyon, Lawrence C., Robins, H. Ian, Hunter, Grant K., Crocker, Ian R., Chao, Samuel T., Pugh, Stephanie L., Armstrong, Terri S.
Zdroj: Neuro-Oncology Advances; Jan-Dec2022, Vol. 4 Issue 1, p1-10, 10p
Databáze: Complementary Index